In contrast, we detected reactivity in 16% of subjects with type 1 diabetes for C-peptide-IAAP1; reactivities to C-peptide-IAAP2 and C-peptide NPY were also higher than those reported by Baker et al. The gene discussed is NPY; the disease is type 1 diabetes mellitus.